fbpx
QQQ
+ 1.31
311.52
+ 0.42%
DIA
-5.22
319.22
-1.66%
SPY
-2.36
384.73
-0.62%
TLT
+ 4.58
133.96
+ 3.31%
GLD
-4.03
169.90
-2.43%

Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ROE

by
February 21, 2014 4:35 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ROE

Below are the top drugs-generic stocks on the NASDAQ in terms of return on equity.

The trailing-twelve-month return on equity at Akorn (NASDAQ: AKRX) is 20.78%. Akorn’s revenue for the same period is $304.28 million.

The trailing-twelve-month return on equity at Salix Pharmaceuticals (NASDAQ: SLXP) is 17.90%. Salix Pharma’s operating margin for the same period is 26.47%.

The trailing-twelve-month return on equity at Mylan (NASDAQ: MYL) is 17.73%. Mylan’s EPS for the same period is $1.52.

The trailing-twelve-month return on equity at Sagent Pharmaceuticals (NASDAQ: SGNT) is 16.09%. Sagent Pharma’s profit margin for the same period is 12.09%.

Posted-In:

Trading Ideas

Related Articles

33 Stocks Moving in Wednesday's Pre-Market Session

Gainers Greenpro Capital Corp. (NASDAQ: GRNQ) shares rose 47.8% to $1.22 in pre-market trading after jumping over 33% on Tuesday. read more

96 Biggest Movers From Yesterday

Gainers Mmtec, Inc. (NASDAQ: MTC) shares climbed 86.4% to close at $2.05 on Tuesday after reporting its financial results for the year ended December 31, 2019. Revenues jumped 647% to $200,797, in 2019. read more

61 Stocks Moving In Tuesday's Mid-Day Session

Gainers Mmtec, Inc. (NASDAQ: MTC) shares jumped 98.2% to $2.18 in pre-market trading after reporting its financial results for the year ended December 31, 2019. Revenues jumped 647% to $200,797, in 2019. read more

28 Stocks Moving in Tuesday's Pre-Market Session

Gainers Mmtec, Inc. (NASDAQ: MTC) shares rose 77.2% to $1.95 in pre-market trading after reporting its financial results for the year ended December 31, 2019. Revenues jumped 647% to $200,797,in 2019. read more